As we did not observe any clinical CRS, we used 2 key inflammatory cytokines after HCT (interleukin 6 [IL-6] and tumor necrosis factor receptor 1 [TNFR1]) as surrogates for subclinical CRS. The gene discussed is TNFRSF1A; the disease is congenital rubella syndrome.